Advertisement
News
Subscribe to MDT Magazine News

Navinta LLC is Pleased to Announce US FDA Approval of Sodium Ferric Gluconate Injection in Sucrose a generic equivalent of Ferrlecit® Injection by Sanofi Aventis Based on Its...

March 31, 2011 8:37 am | by Bio-Medicine.Org | Comments

EWING, N.J., March 31, 2011 /- Navinta's proprietary complex pharmaceutical ingredient, Sodium Ferric Gluconate as covered under Navinta's US Patent 7,179,939 and US Drug Master File is a key component in the recent approval of GeneraMedix Inc.'s ANDA for Sodium Ferric Gluconate Complex...

TOPICS:

Engineers Without Borders Earns Accolades, Fundraises for Cameroon

March 31, 2011 7:39 am | by Georgia Tech Institute of Technology | Comments

Congratulations go to the Georgia Tech chapter of Engineers Without Borders (EWB-GT), which was honored for its creation of a sustainable solar sanitation system at the National Collegiate Inventors and Innovators Alliance's Open Minds competition last weekend in Washington, D.C. The team...

Power-One, Inc. secures $150 million in revolver financing led by Bank of America Merrill Lynch

March 31, 2011 7:39 am | by I-Micronews | Comments

Power-One, Inc. has closed a 3-year, $150 million revolver for general corporate purposes, including expansion of design, production, service and sales of its renewable energy inverters in the North American and Asian markets.

Advertisement

Alpha and Omega Semiconductor introduces first generation Alpha-MOS Super-Junction technology

March 31, 2011 7:39 am | by I-Micronews | Comments

High-voltage super junction MOSFET enables high efficiency AC-DC conversion.

Reportlinker Adds Cardiac Marker Diagnostic Testing Markets

March 31, 2011 6:34 am | by Bio-Medicine.Org | Comments

NEW YORK, March 31, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Cardiac Marker Diagnostic Testing Markets http://www.reportlinker.com/p089570/Cardiac-Marker-Diagnostic-Testing-Markets.html The purpose of this TriMark Publications...

TOPICS:

Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing

March 31, 2011 6:34 am | by Bio-Medicine.Org | Comments

NEW YORK, March 31, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Molecular Diagnostics in Infectious Disease Testing http://www.reportlinker.com/p0368860/Molecular-Diagnostics-in-Infectious-Disease-Testing.html This TriMark...

TOPICS:

Consumer Information on: Medtronic & #xae; InterStim & #xae; Therapy System - P080025

March 31, 2011 6:30 am | by U.S. Food & Drug Administration | Comments

The InterStim® Therapy System is a surgically implanted device used to help a patient reduce the number of bowel accidents (fecal incontinence)2. The InterStim® Therapy System has several components: a neurostimulator which delivers an electrical pulse...

TOPICS:

Dentsply board boosts buyback authorization

March 31, 2011 5:45 am | by The Associated Press | Comments

Dental products company Dentsply International Inc. said Thursday that its board of directors increased the company's authorization to repurchase shares under its stock repurchase program.The company can now buy back up to 34 million shares, up from 22 million shares previously. The company has...

Advertisement

RXi buying Apthera for $7M, getting late-stage drug

March 31, 2011 5:38 am | by Mass High Tech: The Journal of New England Technology | Comments

RXi Pharmaceuticals Corp. plans to acquire Apthera Inc., an Arizona biotechnology company developing therapies for breast and other cancers, in a stock deal worth about $7.2 million. At the same time, RXI president and CEO Noah D. Beerman will be replaced by board member Mark Ahn in both roles.

Summary Information for: Medtronic & #xae; InterStim & #xae; Therapy System

March 31, 2011 5:37 am | by U.S. Food & Drug Administration | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Medtronic® InterStim® Therapy System (P080025).

Summary Information for: Gel-One

March 31, 2011 5:37 am | by U.S. Food & Drug Administration | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Gel-One (P080020).

Ventana Medical Systems, Inc. Launches Virtuoso Software for Digital Pathology

March 31, 2011 5:36 am | by Bio-Medicine.Org | Comments

TUCSON, Ariz., March 31, 2011 /- Ventana Medical Systems , Inc., a member of the Roche Group, announced today the availability of its next generation Virtuoso digital pathology application software.   (Photo: http://photos.prnewswire.com/prnh/20110331/LA74593 ) The new version of...

TOPICS:

2011 ACCF/AHA Guidelines Incorporate New Recommendation for Platelet Reactivity Testing

March 31, 2011 5:35 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 31, 2011 /- Accumetrics, Inc., developer of the VerifyNow® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced today that a new recommendation for platelet reactivity testing has...

TOPICS:

Syndax Pharmaceuticals Announces Entinostat Data at 102nd Annual American Association for Cancer Research Meeting

March 31, 2011 5:34 am | by Bio-Medicine.Org | Comments

WALTHAM, Mass., March 31, 2011 /- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced 11 posters on entinostat, an oral, highly selective, class I histone deacetylase (HDAC) inhibitor, will be presented at the 102nd Annual American Association for...

TOPICS:

NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development

March 31, 2011 5:34 am | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., March 31, 2011 /- NewCardio, Inc., (OTC Bulletin Board: NWCI ) a cardiovascular diagnostic solutions developer, announced today that the Company has been invited to present the results of a recent QTinno ® performance study at an upcoming conference entitled...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading